EE282 Financial Burden of Progression of Chronic Myeloid Leukemia (CML) Patients Who Failed Two or More Tyrosine Kinase Inhibitors Treatment in the Brazilian Private Market Perspective

Jun 1, 2023, 00:00 AM
10.1016/j.jval.2023.03.583
https://www.valueinhealthjournal.com/article/S1098-3015(23)00683-6/fulltext
Section Title :
Section Order : 10068
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00683-6&doi=10.1016/j.jval.2023.03.583
HEOR Topics :
Tags :
Regions :